Compare TEVA & LULU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | LULU |
|---|---|---|
| Founded | 1901 | 1998 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 19.9B |
| IPO Year | N/A | 2007 |
| Metric | TEVA | LULU |
|---|---|---|
| Price | $28.38 | $190.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 28 |
| Target Price | $27.00 | ★ $228.77 |
| AVG Volume (30 Days) | ★ 11.4M | 3.1M |
| Earning Date | 11-05-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.74 |
| EPS | 0.62 | ★ 14.72 |
| Revenue | ★ $16,776,000,000.00 | $10,904,036,000.00 |
| Revenue This Year | $4.74 | $5.67 |
| Revenue Next Year | $0.48 | $4.41 |
| P/E Ratio | $46.12 | ★ $12.91 |
| Revenue Growth | 0.02 | ★ 9.16 |
| 52 Week Low | $12.47 | $159.25 |
| 52 Week High | $28.68 | $423.32 |
| Indicator | TEVA | LULU |
|---|---|---|
| Relative Strength Index (RSI) | 80.93 | 68.55 |
| Support Level | $24.01 | $178.90 |
| Resistance Level | $26.96 | $185.07 |
| Average True Range (ATR) | 0.68 | 5.56 |
| MACD | 0.19 | 2.01 |
| Stochastic Oscillator | 94.65 | 94.04 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 780 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.